Abstract:Background Apical membrane antigen 1 (AMA-1) and merozoite surface protein 1 (MSP1) of Plasmodium falciparum are two leading blood-stage malaria vaccine candidates. A P. falciparum chimeric protein 2.9 (PfCP-2.9) has been constructed as a vaccine candidate, by fusing AMA-1 domain III (AMA-1 (III)) with a C-terminal 19 kDa fragment of MSP1 (MSP1-19) via a 28-mer peptide hinge. PfCP-2.9 was highly immunogenic in animal studies, and antibodies elicited by the PfCP-2.9 highly inhibited parasite growth in vitro . This study focused on locating the distribution of epitopes on PfCP-2.9. Methods A panel of anti-PfCP-2.9 monoclonal antibodies (mAbs) were produced and their properties were examined by Western blot as well as in vitro growth inhibition assay (GIA). In addition, a series of PfCP-2.9 mutants containing single amino acid substitution were produced in Pichia pastoris . Interaction of the mAbs with the PfCP-2.9 mutants was measured by both Western blot and enzyme-linked immunosorbent assay (ELISA). Results Twelve mAbs recognizing PfCP-2.9 chimeric protein were produced. Of them, eight mAbs recognized conformational epitopes and six mAbs showed various levels of inhibitory activities on parasite growth in vitro . In addition, seventeen PfCP-2.9 mutants with single amino acid substitution were produced in Pichia pastoris for interaction with mAbs. Reduced binding of an inhibitory mAb (mAb7G), was observed in three mutants including M62 (Phe 491 →Ala), M82 (Glu 511 →Gln) and M84 (Arg 513 →Lys), suggesting that these amino acid substitutions are critical to the epitope corresponding to mAb7G. The binding of two non-inhibitory mAbs (mAbG11.12 and mAbW9.10) was also reduced in the mutants of either M62 or M82. The substitution of Leu 31 to Arg resulted in completely abolishing the binding of mAb1E1 (a blocking antibody) to M176 mutant, suggesting that the Leu residue at this position plays a crucial role in the formation of the epitope. In addition, the Asn 15 residue may also play an important role in the global folding of PfCP-2.9, as its substitution by Arg lead to reduced binding of most mAbs and abolishing the binding of mAb6G and mAbP5-W12. Conclusions This study provided valuable information on epitopes of PfCP-2.9 vaccine candidate through generation of a panel of mAbs and a series of PfCP-2.9 mutants. The information may prove to be useful for designing more effective malaria vaccines against blood-stage parasites.

Expression and immunogenicity analysis of membrane surface protein 2 of Anaplasma marginale

CLONE AND PROKARYOTIC EXPRESSION OF MSP5 GENE FOR ANAPLASMA MARGINALE

Immunogenieity Analysis of 42 Kda C-terminal Region of Merozoite Surface Protein 1 of Plasmodiun Falciparum Expressed in Rosetta Gami

Genomic and proteomic approaches to vaccine candidate identification for Anaplasma marginale

Analysis of recombinant merozoite surface protein-1 of Plasmodium falciparum expressed in mammalian cells

Cloning and sequence analysis of the MSP4 gene of Hunan province isolates of Anaplasma marginale

Merozoite Surface Protein 2 of Plasmodium Falciparum: Expression, Structure, Dynamics, and Fibril Formation of the Conserved N-terminal Domain.

The Prokaryotic Expression and Immune Characteristic Analysis of Predicted B Cell Epitope in Streptococcus Suis Type 2 (SS2) Lysozyme Release Protein (MRP)

Synthesis and Expression of 42 Kda C-terminal Region of the Major Merozoite Surface Protein1 (MSP1-42) of Plasmodium Falciparum in Rosetta Gami

Molecular Identification and Bioinformatics Analysis of Anaplasma marginale Moonlighting Proteins as Possible Antigenic Targets

Solution Conformation, Backbone Dynamics and Lipid Interactions of the Intrinsically Unstructured Malaria Surface Protein MSP2

Construction of multiple antigenic peptide and the immunity analysis

[Expression and Immunogenicity Evaluation of Ectodomain and Subdomains of Plasmodium Berghei Apical Membrane Antigen 1].

Predicton and Identification of Antigenic Epitopes in Genus-Specific Outer Membrane Proteins OmpL1 and LipL21 of Leptospira Interrogans

Epitope Mapping of PfCP-2.9, an Asexual Blood-Stage Vaccine Candidate of Plasmodium Falciparum

Detection of Anaplasma marginale,Anaplasma centrale,and Anaplasma ovis by Nested Polymerase Chain Reaction Assay

[Synthesis and Expression of 42 Kd C-terminal Region of the Major Merozoite Surface Protein (MSP1 - 42) of P. Falciparum 3D7 Strain in Pichia Pastoris].

Immunogenicity of Outer Membrane Proteins VirB9-1 and VirB9-2, a Novel Nanovaccine against Anaplasma marginale

Expression and the Immune Response of the EGF2 Domain in the Merozoite Surface Protein 1 of Plasmodium Faciparum

Blood-Stage Vaccine Candidate of Plasmodium Falciparum

Prokaryotic expression and localization of Mycoplasma gallisepticum PstS protein